Leiomyosarcoma of the breast: A pathologic and comparative genomic hybridization study of two cases

Cancer Genetics and Cytogenetics

Volumn 149, Issue 1, 2004, Pages 53-57

  Lee, Jiyun ^a   Li, Shibo ^a   Torbenson, Michael ^b   Liu, Qiong Z ^a   Lind, Stuart ^a   Mulvihill, John J ^a   Bane, Barbara ^a   Wang, Jianzhou ^a,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Center for Advanced Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA ACTIN; BIOCHEMICAL MARKER; DESMIN;

ADULT; ARTICLE; BREAST SARCOMA; CANCER PATIENT; CASE REPORT; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOLOGY; EPITHELIUM; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEIOMYOSARCOMA; MICROSCOPY; MITOSIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SOFT TISSUE SARCOMA; SPINDLE CELL; TUMOR CELL; TUMOR VOLUME; UTERUS MYOMA; UTERUS SARCOMA;

EID: 0842346026     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00286-3     Document Type: Article

References (38)

1. Rosen P.P. Sarcoma. Rosen P.P. Rosen's breast pathology. 1997;710-713 Lippincott-Raven, Philadelphia.
2. Elston W.C., Ellis I.O., Pinder S.E. Miscellaneous malignant tumors. Elston W.C., Ellis I.O. The breast. 1998;449-451 Churchill Livingstone, London.
3. Bell K.A., Van Deerlin P.G., Feinberg R.F., du Manoir S., Haddad B.R. Diagnosis of aneuploidy in archival, paraffin-embedded pregnancy-loss tissues by comparative genomic hybridization. Fertil Steril. 75:2001;374-379.
4. Lee J.Y., Lee C.H., Shim S.H., Seo H.K., Kyhm J.H., Cho S., Cho Y.H. Molecular cytogenetic analysis of the monoblastic cell line U937: karyotype clarification by G-banding, whole chromosome painting, microdissection and reverse painting, and comparative genomic hybridization. Cancer Genet Cytogenet. 137:2002;124-132.
5. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 10:1994;231-243.
6. Dal Cin P., Boghosian L., Crickard K., Sandberg A.A. t(10;17) as the sole chromosome change in a uterine leiomyosarcoma. Cancer Genet Cytogenet. 32:1988;263-266.
7. Sait S.N.J., Dal Cin P., Sandberg A.A. Consistent chromosome changes in leiomyosarcoma. Cancer Genet Cytogenet. 35:1988;47-50.
8. Boghosian L., Dal Cin P., Turc-Carel C., Rao U., Karakousis C., Sait S.J., Sandberg A.A. Three possible cytogenetic subgroups of leiomyosarcomas. Cancer Genet Cytogenet. 43:1989;39-49.
9. Nilbert M., Mandahl N., Heim S., Rydholm A., Helm G., Willen H., Baldetorp B. Complex karyotype changes, including rearrangement of 12q13 and 14q24, in two leiomyosarcomas. Cancer Genet Cytogenet. 48:1990;217-223.
10. Fletcher J.A., Morton C.C., Pavelka K., Lage J.M. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Cancer Res. 50:1990;4092-4097.
11. Laxman R., Currie J.L., Kurman R.J., Dudzinski M., Griffin C.A. Cytogenetic profile of uterine sarcomas. Cancer. 71:1993;1283-1288.
12. Sreekantaiah C., Davies J.R., Sandberg A.A. Chromosomal abnormalities in leiomyosarcomas. Am J Pathol. 142:1993;293-305.
13. Han K., Lee W., Harris C., Simsiman R.C., Lee K., Kang C., Meisner L.F. Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH in archival tissue. Cancer Genet Cytogenet. 74:1994;19-24.
14. Packenham J.P., Du Manoir S., Schrock E., Risinger J.I., Dixon D., Denz D.N., Evans J.A., Berchuck A., Barrett J.C., Devereux T.R., Thomas R. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog. 19:1997;273-279.
15. El-Rifai W., Sarlomo-Rikala M., Knuutila S., Miettinen M. DNA copy number changes in development of progression in leiomyosarcomas of soft tissues. Am J Pathol. 153:1998;985-990.
16. Otano-Joos M., Mechtersheimer G., Ohl S., Lehnert T., Willeke F., Moller P., Otto H.F., Lichter P., Joos S. Analysis of chromosome copy number changes in leiomyosarcoma through molecular cytogenetic methods. [in German] Verh Dtsch Ges Pathol. 82:1998;207-209.
17. Parente F., Grosgeorge J., Coindre J.M., Terrier P., Vilain O., Turc-Carel C. Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors. Cancer Genet Cytogenet. 115:1999;89-95.
18. Quade B.J., Pinto A.P., Howard D.R., Peters W.A. 3rd, Crum C.P. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma. Am J Pathol. 154:1999;945-950.
19. Levy B., Mukherjee T., Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet. 121:2000;1-8.
20. Cameron H.M., Hamplerl H., Warambo W. Leiomyosarcoma of the breast originating from myothelium (myoepithelium). J Pathol. 114:1974;89-92.
21. Hernandez F.J. Leiomyosarcoma of the male breast originating in the nipple. Am J Surg Pathol. 2:1978;299-304.
22. Wunder J., Czitrom A., Kandel R., Andrulis I. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst. 83:1991;194-200.
23. Kruzelock R.P., Hansen M.F. Molecular genetics and cytogenetics of sarcomas. Hematol Oncol Clin North Am. 9:1995;513-540.
24. Stilgenbauer S., Nickolenko J., Wilhelm J., Wolf S., Weits S., Dohner K., Boehm T., Dohner H., Lichter P. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene. 16:1998;1891-1897.
25. Dahlen A., Debiec-Rychter M., Pedeutour F., Domanski H.A., Hoglund M., Bauer H.C., Rydholm A., Sciot R., Mandahl N., Mertens F. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer. 103:2003;616-623.
26. Lin C., Meitner P.A., Terek R.M. PTEN mutation is rare in chondrosarcoma. Diagn Mol Pathol. 11:2002;22-26.
27. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
28. Waitie K.A., Eng C., Protean P.T.E.N. form and function. Am J Hum Genet. 70:2002;829-844.
29. Wechsler D.S., Shelly C.A., Dang C.V. Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics. 32:1996;466-470.
30. Atkin N.B. Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet. 21:1986;279-285.
31. Forus A., Weghuis D.O., Smeets D., Fodstad O., Myklebost O., van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas: I. occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer. 14:1995;8-14.
32. Forus A., Berner J.M., Meza-Zepeda L.A., Saeter G., Mischke D., Fodstad O., Myklebost O. Molecular characterization of a novel amplicon at 1q21-q23 frequently observed in human sarcomas. Br J Cancer. 78:1998;495-503.
33. Tarkkanen M., Karhu R., Kallioniemi A., Elomaa I., Kivioja A., Nevalainen J., Bohling T., Karaharju E., Hyytinen E., Knuutila S., Kallioniemi O.P. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res. 55:1995;1334-1338.
34. Knuutila S., Bjorkqvist A.M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.M., Vidgren V., Zhu Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol. 152:1997;1107-1123.
35. Papa F.R., Hochstrasser M. The yeast DOA4 gene encodes a deubiquitination enzyme related to a product of the human tre-2 oncogene. Nature. 366:1993;313-319.
36. Hochstrasser M. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol. 7:1995;215-223.
37. Wilkinson K.D. Roles of ubiquitinylation on proteolysis and cellular regulation. Annu Rev Nutr. 15:1995;161-189.
38. Carrano A.C., Eytan E., Hershko A., Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1:1999;193-199.